PharmaCielo Ltd. provided an update on its ongoing Good Manufacturing Practices (GMP) compliance process. As planned, the Company is preparing itself for the GMP audit process in partnership with NODO Interactivo ("NODO"), a consultancy specializing in the implementation and maintenance of GMP and Good Laboratory Practice (GLP) quality management systems for the pharmaceutical, cosmetic, food and related industries. PharmaCielo expects to receive Colombian GMP certification during the first quarter of this year. The Company's Rionegro facility is Colombia's largest cannabis processing centre, capable of processing 360 tonnes of biomass annually. In addition, PharmaCielo Mexico, the Company's joint venture ("JV") with MINO Labs S.A. de C.V. ("MINO Labs"), has initiated a GMP pre-audit process. This move comes in tandem with a recent announcement by the Mexican government that it has published a much-anticipated legal framework for the medical cannabis space, including a provision for the import of medicinal extracts and products. PharmaCielo Mexico is positioned to be an early mover in this high-potential market and to become a primary supplier of premium-quality medicinal-grade extracts to the Mexican market. The Company expects to receive Mexican GMP certification during the second quarter of 2021.